Search Results
Search for other papers by Mireille N M van Poppel in
Google Scholar
PubMed
Search for other papers by Christopher J Nolan in
Google Scholar
PubMed
Search for other papers by Gernot Desoye in
Google Scholar
PubMed
Introduction Pancreas agenesis (PA) is a very rare condition that causes permanent neonatal diabetes mellitus (PNDM) and pancreatic exocrine insufficiency. It presents most commonly with neonatal hyperglycemia in small for gestational age
Search for other papers by Rebeca Esquivel-Zuniga in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
concentrations of total and free testosterone. Moreover, those males with type 2 diabetes mellitus (T2DM) and obesity or other components of the metabolic syndrome are more likely to have diminished testosterone levels than those with isolated obesity ( 19
Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed
Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Search for other papers by Ana-Claudia Latronico in
Google Scholar
PubMed
Search for other papers by Martin O Savage in
Google Scholar
PubMed
secretion, that modify the concentration of IGF-I, such as malnutrition, liver dysfunction, diabetes mellitus, hypothyroidism, and sex steroid levels ( 13 ). As a further complication, laboratory practices and assays may contribute to the variability in
Search for other papers by Christine Poitou in
Google Scholar
PubMed
Search for other papers by Anthony Holland in
Google Scholar
PubMed
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Laura C G de Graaff in
Google Scholar
PubMed
Search for other papers by Sandrine Bottius in
Google Scholar
PubMed
Search for other papers by Berit Otterlei in
Google Scholar
PubMed
Search for other papers by Maithé Tauber in
Google Scholar
PubMed
, uncontrolled access to food may be allowed substantial weight gain will occur, resulting in physical consequences, such as diabetes mellitus and sleep apnea. Managing the transition to adult life with people with neurodevelopmental syndromes, such as PWS
Search for other papers by Alberto Battezzati in
Google Scholar
PubMed
Search for other papers by Andrea Foppiani in
Google Scholar
PubMed
Search for other papers by Gianfranco Alicandro in
Google Scholar
PubMed
Search for other papers by Arianna Bisogno in
Google Scholar
PubMed
Search for other papers by Arianna Biffi in
Google Scholar
PubMed
Internal Medicine, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy
Search for other papers by Giorgio Bedogni in
Google Scholar
PubMed
Istituto Auxologico Italiano, IRCCS, Obesity Unit - Laboratory of Nutrition and Obesity Research, Department of Endocrine and Metabolic Diseases, Milan, Italy
Search for other papers by Simona Bertoli in
Google Scholar
PubMed
Search for other papers by Giulia De Carlo in
Google Scholar
PubMed
Search for other papers by Erica Nazzari in
Google Scholar
PubMed
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Holl RW & Diabetes Patienten Verlaufsdokumentationssystem Initiative of the German Working Group for Pediatric Diabetology and the German Bundesministerium für Bildung und Forschung Competence Net for Diabetes Mellitus . Growth in children and
Search for other papers by Régis Coutant in
Google Scholar
PubMed
Pediatric team of the Clinical Investigation Center 9302/INSERM, Hospital of Children, Toulouse, France
Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France
Search for other papers by Maithé Tauber in
Google Scholar
PubMed
Search for other papers by Béatrice Demaret in
Google Scholar
PubMed
Search for other papers by Robin Henocque in
Google Scholar
PubMed
Search for other papers by Yves Brault in
Google Scholar
PubMed
Search for other papers by François Montestruc in
Google Scholar
PubMed
Patient-Reported Outcomes Unit (PROQOL), UMR 1123, University Paris Cité, INSERM, Paris, France
Search for other papers by Olivier Chassany in
Google Scholar
PubMed
Search for other papers by Michel Polak in
Google Scholar
PubMed
Search for other papers by the QOLITHOR Study Group in
Google Scholar
PubMed
hypothalamic pituitary axis hormonal deficiencies and/or diabetes insipidus should be on an optimized and stable treatment regimen for at least 3 months prior to inclusion. Children with cancer history, psychosocial dwarfism, diabetes mellitus, human
Search for other papers by Patrizia Bruzzi in
Google Scholar
PubMed
Search for other papers by Silvia Vannelli in
Google Scholar
PubMed
Search for other papers by Emanuela Scarano in
Google Scholar
PubMed
Search for other papers by Natascia Di Iorgi in
Google Scholar
PubMed
Search for other papers by Maria Parpagnoli in
Google Scholar
PubMed
Search for other papers by MariaCarolina Salerno in
Google Scholar
PubMed
Search for other papers by Marco Pitea in
Google Scholar
PubMed
Search for other papers by Maria Elisabeth Street in
Google Scholar
PubMed
Search for other papers by Andrea Secco in
Google Scholar
PubMed
Search for other papers by Adolfo Andrea Trettene in
Google Scholar
PubMed
Search for other papers by Malgorzata Wasniewska in
Google Scholar
PubMed
Search for other papers by Nicola Corciulo in
Google Scholar
PubMed
Search for other papers by Gianluca Tornese in
Google Scholar
PubMed
Search for other papers by Maria Felicia Faienza in
Google Scholar
PubMed
Search for other papers by Maurizio Delvecchio in
Google Scholar
PubMed
Search for other papers by Simona Filomena Madeo in
Google Scholar
PubMed
Search for other papers by Lorenzo Iughetti in
Google Scholar
PubMed
. Patients affected by other endocrine diseases (e.g. central precocious puberty, congenital adrenal hyperplasia, hypothyroidism and type 1 diabetes mellitus), organic brain lesion and systemic diseases as well as patients taking drugs interfering with height